- The management of polycystic liver disease by tolvaptan
-
Takenaka T, Miura S, Kitajima M
- KMID: 2501318
- Clin Mol Hepatol.
- 2020 Jan;26(1):70-73.
- doi: 10.3350/cmh.2019.0026
-
- CITED
-
- Close
- SHARE
-
- Close
- Prevalence of Fabry Disease in Korean Men with Left Ventricular Hypertrophy
-
Kim WS, Kim HS, Shin J, Park JC, Yoo HW, Takenaka T, Tei C
- KMID: 2438311
- J Korean Med Sci.
- 2019 Feb;34(7):e63.
- doi: 10.3346/jkms.2019.34.e63
BACKGROUND: Fabry disease is an X-linked recessive disorder caused by deficiency of the lysosomal enzyme α-galactosidase A (α-Gal A). Previous studies identified many cases of Fabry disease among men with... -
- CITED
-
- Close
- SHARE
-
- Close
- A Case of Fabry Cardiomyopathy
-
Nah JC, Kim WS, Cho WH, Choi SK, Yoo HW, Takenaka T, Tei C
- KMID: 2225684
- Korean Circ J.
- 2009 Aug;39(8):335-339.
- doi: 10.4070/kcj.2009.39.8.335
In the absence of hypertension, hypertrophic cardiomyopathy is the most common cause of left ventricular hypertrophy (LVH). However, it has been reported that up to 3% of males with unexplained... -
- CITED
-
- Close
- SHARE
-
- Close
